XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Net revenue $ 868,951 $ 828,006 $ 2,547,492 $ 2,352,389
Operating expenses:        
Practice salaries and benefits 586,476 521,832 1,720,279 1,498,268
Practice supplies and other operating expenses 29,497 31,641 88,165 85,679
General and administrative expenses 101,430 93,457 308,210 275,523
Depreciation and amortization 25,116 24,185 76,465 64,010
Total operating expenses 742,519 671,115 2,193,119 1,923,480
Income from operations 126,432 156,891 354,373 428,909
Investment and other income 235 221 1,176 1,249
Interest expense (18,428) (17,215) (54,715) (46,736)
Equity in (losses) earnings of unconsolidated affiliate (240) 796 1,246 2,379
Total non-operating expenses (18,433) (16,198) (52,293) (43,108)
Income before income taxes 107,999 140,693 302,080 385,801
Income tax provision 42,119 44,272 117,811 139,284
Net income 65,880 96,421 184,269 246,517
Net loss attributable to noncontrolling interests   88   318
Net income attributable to MEDNAX, Inc. $ 65,880 $ 96,509 $ 184,269 $ 246,835
Net income attributable to MEDNAX, Inc.:        
Earnings per share, Basic $ 0.71 $ 1.04 $ 2.00 $ 2.67
Earnings per share, Diluted $ 0.71 $ 1.04 $ 1.98 $ 2.65
Weighted average common shares:        
Basic 92,589 92,604 92,348 92,336
Diluted 92,881 93,146 93,014 93,045